Listenly

What is the difference between negotiating PBM rebates versus actually managing pharmacy trend for employers?

Answered at 22:01 in Episode 66 - Designing the Future PBM Model with Judi Health · HR Benecast

— questions searchable right now

What is the difference between negotiating PBM rebates versus actually managing pharmacy trend for employers?

Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions. Nick Van Hook emphasizes that employers must marry drug costs and rebate negotiations with active population management—including formulary strategies, prior authorization, and preventing excess days supply—because discounts alone do not control trend if more units are being pushed out the door or if steerage occurs toward higher-cost products to meet rebate targets.

Nick Van Hook on HR BenecastAll answers from this podcast →
Full answer and detailsRead the whole answer, key facts and every other question from this episode

In short

Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions.

Nick Van Hook, Senior Vice President of National Business Development at Judy Health · Episode 66 - Designing the Future PBM Model with Judi Health · HR Benecast · answer at 22:01

Key takeaways

  • Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions.

Quote to remember

“We wanted to get back to what the core roots of PBM was when they started, and that was be the best administrator, a fee for service organization that had arm's length relationships throughout the supply chain.”

— Nick Van Hook

The full answer · about 3 min

Employers often focus on securing the best discounts and rebates on paper, but without managing the actual units dispensed, trend continues to rise at 10-15% or higher depending on coverage and conditions. Nick Van Hook emphasizes that employers must marry drug costs and rebate negotiations with active population management—including formulary strategies, prior authorization, and preventing excess days supply—because discounts alone do not control trend if more units are being pushed out the door or if steerage occurs toward higher-cost products to meet rebate targets.

Key facts

  • Over 15 years in the pharmacy benefit space (Nick Van Hook's career history)
  • Over 7 years with Judy Health (Nick Van Hook's tenure)
  • 9 years since Judy Health's inception
  • 12 or 13 states with minimum reimbursement requirements based on NADAC plus dispensing fee
  • Specialty spend represents over half of total pharmacy spend for many clients

People, companies and topics mentioned

Judy HealthStarkRxJudyRxHR BenecastNADAC (National Average Drug Acquisition Cost)MedcoExpress ScriptsTraveris

More answers from this episode

 ·  All answers from HR Benecast →
—
—
0:00
0:00